ucsf logo

Charlah Ayers Robinson, MD

Maternal and Fetal Medicine
Prenatal Diagnostic Testing Monterey
415-353-3400
ucsf logo

Charlah Ayers Robinson, MD

Maternal and Fetal Medicine
Prenatal Diagnostic Testing Monterey
415-353-3400

On this page

About me

Dr. Charlah Ayers Robinson is a perinatologist, a specialist in high-risk pregnancies. She seeks to respect and uphold the dignity of all pregnant people by supporting their physical and emotional well-being, providing compassionate care, and offering clear recommendations to their referring doctors.

Robinson earned her medical degree at the Perelman School of Medicine at the University of Pennsylvania. She completed a residency in obstetrics and gynecology and a fellowship in maternal-fetal medicine at the Hospital of the University of Pennsylvania.

In her personal time, Robinson enjoys studying philosophy and is working on a long-term project on pregnancy and culture. She feels privileged to live within walking distance of the beach and the Forest of Nisene Marks State Park, which is her happy place.

Education & training

Board certification

  • Maternal-Fetal Medicine, American Board of Obstetrics and Gynecology
  • Obstetrics & Gynecology, American Board of Obstetrics and Gynecology

Fellowship

  • Maternal and Fetal Medicine, University of Pennsylvania School of Medicine GME

Residency

  • Obstetrics & Gynecology, University of Pennsylvania School of Medicine GME

Internship

  • Obstetrics & Gynecology, Medical College of Pennsylvania Hospital

Degree

  • MD, University of Pennsylvania School of Medicine

My expertise

Locations

    Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.

    For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.